SUMO-1 modification increases human SOD1 stability and aggregation

Biochemical and Biophysical Research Communications

Volumn 347, Issue 2, 2006, Pages 406-412

  Fei, Erkang ^a   Jia, Nali ^a   Yan, Ming ^a   Ying, Zheng ^a   Sun, Qiang ^a   Wang, Hongfeng ^a   Zhang, Tao ^a   Ma, Xiaochuan ^a   Ding, Husheng ^a   Yao, Xuebiao ^a   Shi, Yunyu ^a   Wang, Guanghui ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Copper zinc superoxide dismutase (SOD1); Familial amyotrophic lateral sclerosis (FALS); Sumoylation

Indexed keywords

ARGININE; COPPER ZINC SUPEROXIDE DISMUTASE; LYSINE; MUTANT PROTEIN; SUMO 1 PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME STABILITY; ENZYME SUBSTRATE; FEMALE; HUMAN; HUMAN CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; REGULATORY MECHANISM; STEADY STATE; WILD TYPE;

CELL LINE; ENZYME STABILITY; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LYSINE; MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMO-1 PROTEIN; SUPEROXIDE DISMUTASE; TRANSFECTION; UBIQUITINS;

EID: 33745924415     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.06.092     Document Type: Article

References (41)

1. Selverstone Valentine J., Doucette P.A., and Zittin Potter S. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu. Rev. Biochem. 74 (2005) 563-593
2. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
3. Andersen P.M. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr. Neurol. Neurosci. Rep. 6 (2006) 37-46
4. Liu J., Lillo C., Jonsson P.A., Vande Velde C., Ward C.M., Miller T.M., Subramaniam J.R., Rothstein J.D., Marklund S., Andersen P.M., Brannstrom T., Gredal O., Wong P.C., Williams D.S., and Cleveland D.W. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron 43 (2004) 5-17
5. Sturtz L.A., Diekert K., Jensen L.T., Lill R., and Culotta V.C. A fraction of yeast Cu,Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria. A physiological role for SOD1 in guarding against mitochondrial oxidative damage. J. Biol. Chem. 276 (2001) 38084-38089
6. Valentine J.S., and Hart P.J. Misfolded CuZnSOD and amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 100 (2003) 3617-3622
7. Pasinelli P., Belford M.E., Lennon N., Bacskai B.J., Hyman B.T., Trotti D., and Brown Jr. R.H. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 43 (2004) 19-30
8. Cleveland D.W. From Charcot to SOD1: mechanisms of selective motor neuron death in ALS. Neuron 24 (1999) 515-520
9. Rabizadeh S., Gralla E.B., Borchelt D.R., Gwinn R., Valentine J.S., Sisodia S., Wong P., Lee M., Hahn H., and Bredesen D.E. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc. Natl. Acad. Sci. USA 92 (1995) 3024-3028
10. Takeuchi H., Kobayashi Y., Ishigaki S., Doyu M., and Sobue G. Mitochondrial localization of mutant superoxide dismutase 1 triggers caspase-dependent cell death in a cellular model of familial amyotrophic lateral sclerosis. J. Biol. Chem. 277 (2002) 50966-50972
11. Guegan C., Vila M., Teismann P., Chen C., Onteniente B., Li M., Friedlander R.M., and Przedborski S. Instrumental activation of bid by caspase-1 in a transgenic mouse model of ALS. Mol. Cell Neurosci. 20 (2002) 553-562
12. Shefner J.M., Reaume A.G., Flood D.G., Scott R.W., Kowall N.W., Ferrante R.J., Siwek D.F., Upton-Rice M., and Brown Jr. R.H. Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy. Neurology 53 (1999) 1239-1246
13. Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., Reaume A.G., Scott R.W., and Cleveland D.W. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281 (1998) 1851-1854
14. Son M., Cloyd C.D., Rothstein J.D., Rajendran B., and Elliott J.L. Aggregate formation in Cu,Zn superoxide dismutase-related proteins. J. Biol. Chem. 278 (2003) 14331-14336
15. Watanabe M., Dykes-Hoberg M., Culotta V.C., Price D.L., Wong P.C., and Rothstein J.D. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol. Dis. 8 (2001) 933-941
16. Lin H., Zhai J., and Schlaepfer W.W. RNA-binding protein is involved in aggregation of light neurofilament protein and is implicated in the pathogenesis of motor neuron degeneration. Hum. Mol. Genet. 14 (2005) 3643-3659
17. Howland D.S., Liu J., She Y., Goad B., Maragakis N.J., Kim B., Erickson J., Kulik J., DeVito L., Psaltis G., DeGennaro L.J., Cleveland D.W., and Rothstein J.D. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad. Sci. USA 99 (2002) 1604-1609
18. Taylor J.P., Hardy J., and Fischbeck K.H. Toxic proteins in neurodegenerative disease. Science 296 (2002) 1991-1995
19. Cheroni C., Peviani M., Cascio P., Debiasi S., Monti C., and Bendotti C. Accumulation of human SOD1 and ubiquitinated deposits in the spinal cord of SOD1G93A mice during motor neuron disease progression correlates with a decrease of proteasome. Neurobiol. Dis. 18 (2005) 509-522
20. Urushitani M., Kurisu J., Tsukita K., and Takahashi R. Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis. J. Neurochem. 83 (2002) 1030-1042
21. Puttaparthi K., Wojcik C., Rajendran B., DeMartino G.N., and Elliott J.L. Aggregate formation in the spinal cord of mutant SOD1 transgenic mice is reversible and mediated by proteasomes. J. Neurochem. 87 (2003) 851-860
22. Matunis M.J., Coutavas E., and Blobel G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135 (1996) 1457-1470
23. Muller S., Ledl A., and Schmidt D. SUMO: a regulator of gene expression and genome integrity. Oncogene 23 (2004) 1998-2008
24. Hay R.T. SUMO: a history of modification. Mol. Cell 18 (2005) 1-12
25. Bohren K.M., Nadkarni V., Song J.H., Gabbay K.H., and Owerbach D. A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J. Biol. Chem. 279 (2004) 27233-27238
26. Saitoh H., and Hinchey J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275 (2000) 6252-6258
27. Mahajan R., Delphin C., Guan T., Gerace L., and Melchior F. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88 (1997) 97-107
28. Desterro J.M., Rodriguez M.S., and Hay R.T. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol. Cell 2 (1998) 233-239
29. Desterro J.M., Keegan L.P., Jaffray E., Hay R.T., O'Connell M.A., and Carmo-Fonseca M. SUMO-1 modification alters ADAR1 editing activity. Mol. Biol. Cell 16 (2005) 5115-5126
30. Muller S., Hoege C., Pyrowolakis G., and Jentsch S. SUMO, ubiquitin's mysterious cousin. Nat. Rev. Mol. Cell Biol. 2 (2001) 202-210
31. Johnson E.S., and Gupta A.A. An E3-like factor that promotes SUMO conjugation to the yeast septins. Cell 106 (2001) 735-744
32. Bayer P., Arndt A., Metzger S., Mahajan R., Melchior F., Jaenicke R., and Becker J. Structure determination of the small ubiquitin-related modifier SUMO-1. J. Mol. Biol. 280 (1998) 275-286
33. Huang T.T., Wuerzberger-Davis S.M., Wu Z.H., and Miyamoto S. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 115 (2003) 565-576
34. Steffan J.S., Agrawal N., Pallos J., Rockabrand E., Trotman L.C., Slepko N., Illes K., Lukacsovich T., Zhu Y.Z., Cattaneo E., Pandolfi P.P., Thompson L.M., and Marsh J.L. SUMO modification of Huntingtin and Huntington's disease pathology. Science 304 (2004) 100-104
35. Fu C., Ahmed K., Ding H., Ding X., Lan J., Yang Z., Miao Y., Zhu Y., Shi Y., Zhu J., Huang H., and Yao X. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Oncogene 24 (2005) 5401-5413
36. Zhou W., Ryan J.J., and Zhou H. Global analyses of sumoylated proteins in Saccharomyces cerevisiae. Induction of protein sumoylation by cellular stresses. J. Biol. Chem. 279 (2004) 32262-32268
37. Lin X., Liang M., Liang Y.Y., Brunicardi F.C., and Feng X.H. SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4. J. Biol. Chem. 278 (2003) 31043-31048
38. Buschmann T., Fuchs S.Y., Lee C.G., Pan Z.Q., and Ronai Z. SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53. Cell 101 (2000) 753-762
39. Dorval V., and Fraser P.E. Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein. J. Biol. Chem. 281 (2006) 9919-9924
40. Riley B.E., Zoghbi H.Y., and Orr H.T. SUMOylation of the polyglutamine repeat protein, ataxin-1, is dependent on a functional nuclear localization signal. J. Biol. Chem. 280 (2005) 21942-21948
41. Shinbo Y., Niki T., Taira T., Ooe H., Takahashi-Niki K., Maita C., Seino C., Iguchi-Ariga S.M., and Ariga H. Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities. Cell Death Differ. 13 (2006) 96-108